Importantly, we found systematic differences in chromatin interactions involving important CLL prognostic genes, such as LPL and CD38, between the IGHV-mutated and IGHV-unmutated subtypes. The gene discussed is LPL; the disease is B-cell chronic lymphocytic leukemia.